Medical Ikkou Group Co (TSE:3353) ROCE %: 8.21% (As of Feb. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:3353 Medical Ikkou Group Co Ltd TSE:3353
63 GF Score
Price 円2,841.00
GF Value 円3,534.01
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Medical Ikkou Group Co ROCE %?

Medical Ikkou Group Co TSE:3353 +0.53% 63 ROCE % is 8.21% as of Feb. 2026. GuruFocus rates TSE:3353 with a GF Score™ of 63/100 and a GF Value™ of 円3,534.01 (Modestly Undervalued). The stock has 1 warning sign investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Medical Ikkou Group Co's annualized ROCE % for the quarter that ended in Feb. 2026 was 8.21%.

Medical Ikkou Group Co  (TSE:3353) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Medical Ikkou Group Co ROCE % Related Terms

Medical Ikkou Group Co ROCE % Historical Data

* Premium members only.

The historical data trend for Medical Ikkou Group Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medical Ikkou Group Co ROCE % Chart

Medical Ikkou Group Co Annual Data
Trend Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24 Feb25 Feb26
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.65 6.70 8.31 8.97 8.77

Medical Ikkou Group Co Semi-Annual Data
Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Aug22 Feb23 Aug23 Feb24 Aug24 Feb25 Aug25 Feb26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.76 10.80 7.22 9.11 8.21
TSE:3353
63GF Score
Medical Ikkou Group Co Ltd TSE:3353
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medical Ikkou Group Co ROCE % Calculation

Medical Ikkou Group Co's annualized ROCE % for the fiscal year that ended in Feb. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Feb. 2026 )  (A: Feb. 2025 )(A: Feb. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Feb. 2026 )  (A: Feb. 2025 )(A: Feb. 2026 )
=2127.499/( ( (34231.775 - 11668.666) + (37576.117 - 11617.672) )/ 2 )
=2127.499/( (22563.109+25958.445)/ 2 )
=2127.499/24260.777
=8.77 %

Medical Ikkou Group Co's ROCE % of for the quarter that ended in Feb. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Feb. 2026 )  (Q: Aug. 2025 )(Q: Feb. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Feb. 2026 )  (Q: Aug. 2025 )(Q: Feb. 2026 )
=2089.822/( ( (37914.044 - 12947.677) + (37576.117 - 11617.672) )/ 2 )
=2089.822/( ( 24966.367 + 25958.445 )/ 2 )
=2089.822/25462.406
=8.21 %

(1) Note: The EBIT data used here is two times the semi-annual (Feb. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 8.21% mean?
Medical Ikkou Group Co (TSE:3353) has a ROCE % of 8.21% as of Feb. 2026.
Is Medical Ikkou Group Co's ROCE % too high?
Medical Ikkou Group Co's current ROCE % is 8.21%. The Conglomerates industry median ROCE % is 6.98. Medical Ikkou Group Co's value of 8.21% is 17.6% above this industry median. Overall, Medical Ikkou Group Co has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medical Ikkou Group Co's ROCE % compare to HON and MMM?
Medical Ikkou Group Co's ROCE % of 8.21% can be compared against companies in the Conglomerates industry. The industry median ROCE % is 6.98. Medical Ikkou Group Co's value of 8.21% is 17.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Conglomerates company?
The median ROCE % among Conglomerates companies is 6.98, based on 561 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medical Ikkou Group Co's current ROCE % of 8.21% is 17.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Conglomerates industry, the median ROCE % is 6.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medical Ikkou Group Co's current ROCE % is 8.21%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Ikkou Group Co stock overvalued right now?
Based on GuruFocus' analysis, Medical Ikkou Group Co (TSE:3353) is currently considered Modestly Undervalued. The stock's GF Value™ is 円3,534.01, compared to a current price of 円2,841.00 — trading 19.6% below its estimated fair value. The current ROCE % is 8.21% and 17.6% above the Conglomerates industry median of 6.98. Medical Ikkou Group Co's overall GF Score™ is 63/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Medical Ikkou Group Co (TSE:3353), the current ROCE % is 8.21% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medical Ikkou Group Co (TSE:3353) Overvalued in 2026?

Based on GuruFocus' analysis, Medical Ikkou Group Co stock appears to be undervalued. The current stock price of 円2,841.00 is trading 19.6% below its estimated GF Value™ of 円3,534.01. GuruFocus considers Medical Ikkou Group Co to be Modestly Undervalued.

Key valuation signals for TSE:3353:

  • ROCE %: 8.21%
  • GF Value™: 円3,534.01 vs. price of 円2,841.00 (19.6% below fair value)
  • GF Score™: 63/100 with 1 warning sign
  • Industry Position: 17.6% above the Conglomerates median

No single metric tells the full story. See the TSE:3353 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medical Ikkou Group Co Business Description

Address 501 62 Fujikata, Mie Prefecture, Tsu, JPN, 514-0815
Medical Ikkou Group Co Ltd is engaged in Dispensing pharmacy business, healthcare business, pharmaceutical wholesale business, real estate business, and investment business.
63GF Score

Get the complete analysis for TSE:3353

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,841.00
Price
円3,534.01
GF Value